Melanin Synthesis Inhibitor
- Name
- Melanin Synthesis Inhibitor
- Accession Number
- DBCAT003530
- Description
Not Available
- Drugs
Drug Drug Description Hydroquinone A topical brightening agent used for the treatment of skin disorders associated with hyperpigmentation including melasma, post-inflammatory hyperpigmentation, sunspots, and freckles. Methyl undecenoyl leucinate Methyl undecenoyl leucinate is an active ingredient in whitening creams. It is an α-MSH antagonist that inhibits melanin synthesis and tyrosinase activity and reduces expression of various melanogenic genes. - Drugs & Drug Targets
Drug Target Type Hydroquinone Tyrosinase target Hydroquinone Serum albumin carrier Hydroquinone Lysosomal alpha-glucosidase enzyme Hydroquinone Cysteinyl leukotriene receptor 1 target